PLANETARY GENETICS - Key Persons

Job Titles:

• CO - FOUNDER
• CO - FOUNDER & ADVISOR, BUSINESS ANALYTICS

A business development leader with extensive experience in emerging technology projects, market analyses, and capital investment activities. His work experience includes creating business cases for environmental biotech and cleantech ventures, supporting multiple Department of Defense contracts, and working at the Centers for Disease Control and Prevention (CDC). He holds an MS in Biotechnology and an MBA from Johns Hopkins University.

Job Titles:

• CO - FOUNDER & ADVISOR, COMMERCIAL STRATEGY

More than 20 years of successful results in biotechnology sales and marketing across molecular diagnostics for infectious disease, prenatal, ophthalmology and oncology. Deep experience in a broad array of commercial roles of increasing responsibility including strategic partnerships, product development, clinical validation, reimbursement strategy, product launches, KOL engagement, medical education programs, sales operations and leading high performing sales and marketing teams.

Job Titles:

• CO - FOUNDER & ADVISOR, SCIENCE & TECHNOLOGY

Highly experienced executive in managing a diverse group of stakeholders and teams, including C-level executives, middle managers, investors, clinicians, academicians, and patient advocates, required for the execution of complex technical platforms, the generation of first product instance, and meaningful patient outcomes. Over 30 years experience developing molecular technology platforms from concept to data validation in a variety of therapeutic areas and technologies including genomics, gene and cell therapies.

Job Titles:

• FOUNDER & PRINCIPAL PARTNER

Biotechnology developer, technology analyst, business and corporate strategist, and public health innovator with over 20 years experience advancing biotechnologies to promote healthier communities and environments. Worked to develop and deploy advanced technologies for human health, environmental health, biosecurity, biodefense, sustainable food production, consumer products, and conservation. Developed groundbreaking FDA-cleared products including current molecular tests for safety screening of the U.S. blood supply (HIV, HCV, HBV, West Nile virus) and launched the APTIMA molecular diagnostics platform with the first FDA-cleared combined chlamydia and gonorrhea molecular test. Participated in the deployment of pioneering mobile HIV / CD4 diagnostics for low resource settings in Sub-Saharan Africa. Deep experience advancing several synthetic biology and genetic engineering technologies, as well as first-in-class gene-edited and genetically engineered products regulated by FDA, USDA, and EPA. Dedicated to developing medicines, biothreat detection systems, and environmental interventions aimed at improving global public health and biosecurity.